INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
PS

Pearce Samantha

EVP, Chief Commercial OfficerCIK 0001805688

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score34
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$204K
780 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcEVP, Chief Commercial Officer · Jan 21, 2026
19
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M
$756K
6,907 sh
May 28, 2026
Jun 1, 2026
traded May 28, 2026
+4d
SEC FORM 4

Evidence

34
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$1.63M
6,907 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
6,907 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

19
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
3,637 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

21
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$274K
1,599 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence